Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Glycine decarboxylase deficiency–induced motor dysfunction in zebrafish is rescued by counterbalancing glycine synaptic level
Raphaëlle Riché, Meijiang Liao, Izabella A. Pena, Kit-Yi Leung, Nathalie Lepage, Nicolas D.E. Greene, Kyriakie Sarafoglou, Lisa A. Schimmenti, Pierre Drapeau, Éric Samarut
Raphaëlle Riché, Meijiang Liao, Izabella A. Pena, Kit-Yi Leung, Nathalie Lepage, Nicolas D.E. Greene, Kyriakie Sarafoglou, Lisa A. Schimmenti, Pierre Drapeau, Éric Samarut
View: Text | PDF
Research Article Genetics Neuroscience

Glycine decarboxylase deficiency–induced motor dysfunction in zebrafish is rescued by counterbalancing glycine synaptic level

  • Text
  • PDF
Abstract

Glycine encephalopathy (GE), or nonketotic hyperglycinemia (NKH), is a rare recessive genetic disease caused by defective glycine cleavage and characterized by increased accumulation of glycine in all tissues. Here, based on new case reports of GLDC loss-of-function mutations in GE patients, we aimed to generate a zebrafish model of severe GE in order to unravel the molecular mechanism of the disease. Using CRISPR/Cas9, we knocked out the gldc gene and showed that gldc–/– fish recapitulate GE on a molecular level and present a motor phenotype reminiscent of severe GE symptoms. The molecular characterization of gldc–/– mutants showed a broad metabolic disturbance affecting amino acids and neurotransmitters other than glycine, with lactic acidosis at stages preceding death. Although a transient imbalance was found in cell proliferation in the brain of gldc–/– zebrafish, the main brain networks were not affected, thus suggesting that GE pathogenicity is mainly due to metabolic defects. We confirmed that the gldc–/– hypotonic phenotype is due to NMDA and glycine receptor overactivation, and demonstrated that gldc–/– larvae depict exacerbated hyperglycinemia at these synapses. Remarkably, we were able to rescue the motor dysfunction of gldc–/– larvae by counterbalancing pharmacologically or genetically the level of glycine at the synapse.

Authors

Raphaëlle Riché, Meijiang Liao, Izabella A. Pena, Kit-Yi Leung, Nathalie Lepage, Nicolas D.E. Greene, Kyriakie Sarafoglou, Lisa A. Schimmenti, Pierre Drapeau, Éric Samarut

×

Figure 2

Zebrafish gldc is expressed in the CNS and its loss of function induces glycine accumulation.

Options: View larger image (or click on image) Download as PowerPoint
Zebrafish gldc is expressed in the CNS and its loss of function induces ...
(A) In situ hybridization of gldc transcript at 8, 18, 24, 32, and 42 hours after fertilization (hpf) showing the expression in the brain and spinal cord as well as in the intestine at later stages. dpf, days after fertilization. (B) CRISPR/Cas9 mutagenesis targeting the 4th exon of gldc led to substitution of 2 nucleotides and deletion of 5 nucleotides. These DNA mutations in gldc–/– fish induce a melting curve shift compared with gldc+/+ that allows for rapid genotyping. (C) Scheme of several nonsense mutations identified in patients leading to insertion of stop codons in the glycine cleavage domain of the human GLDC protein. Red indicates the mutant variant of the glycine encephalopathy patient described here; and the location of the CRISPR mutation in the zebrafish GLDC protein. ter, terminal. (D) RT-qPCR analysis of gldc mRNA levels reveals a significant decrease in gldc–/+ and gldc–/– compared with gldc+/+ fish, at 7 dpf (ANOVA, ***P < 0.0004; **P < 0.005, n > 10, N = 3). LC-MS dosage of glycine levels in whole 7 dpf larvae reveals a significant increase in gldc–/–, but not gldc–/+, compared with gldc+/+ (ANOVA, ****P <0.0001, n = 3, n = 3). Boxes and whiskers represent minimum and maximum values, and a line shows the median value. Each dot corresponds to an individual experiment (N) with at least 5 fish (n > 5).

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts